ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Management of Antithrombin Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-33R17269
Home | Market Reports | Health| Pharmacy
Global Management of Antithrombin Market Research Report 2024
BUY CHAPTERS

Global Management of Antithrombin Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33R17269
Report
October 2025
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
REVO Biologics Inc
Takeda
Kedrion S p A
CSL Limited
Scripps Laboratories Inc
Lee Biosolutions

Management of Antithrombin Market

The global Management of Antithrombin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Management of Antithrombin is a protein in the blood that plays a crucial role in regulating blood clotting. It is a natural anticoagulant that inhibits or blocks the activity of certain clotting factors, specifically thrombin and factor Xa, preventing excessive clotting and maintaining blood flow.
From a downstream perspective, Diagnostics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Management of Antithrombin leading manufacturers including Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions, etc., dominate supply; the top five capture approximately % of global revenue, with Grifols leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Management of Antithrombin market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Management of Antithrombin Market Report

Report Metric Details
Report Name Management of Antithrombin Market
Segment by Type
Segment by Application
  • Diagnostics
  • Therapeutics
  • Research
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Management of Antithrombin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Management of Antithrombin Market report?

Ans: The main players in the Management of Antithrombin Market are Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions

What are the Application segmentation covered in the Management of Antithrombin Market report?

Ans: The Applications covered in the Management of Antithrombin Market report are Diagnostics, Therapeutics, Research

What are the Type segmentation covered in the Management of Antithrombin Market report?

Ans: The Types covered in the Management of Antithrombin Market report are Liquid, Lyophilized

Recommended Reports

Anticoagulant Therapy

Blood Coagulation Factors

Haemostasis and Treatment

1 Study Coverage
1.1 Introduction to Management of Antithrombin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Management of Antithrombin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market Segmentation by Application
1.3.1 Global Management of Antithrombin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Management of Antithrombin Revenue Estimates and Forecasts 2020-2031
2.2 Global Management of Antithrombin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Management of Antithrombin Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Management of Antithrombin Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Liquid Market Size by Players
3.3.2 Lyophilized Market Size by Players
3.4 Global Management of Antithrombin Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Management of Antithrombin Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Management of Antithrombin Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Management of Antithrombin Market Size by Type (2020-2031)
6.4 North America Management of Antithrombin Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Management of Antithrombin Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Management of Antithrombin Market Size by Type (2020-2031)
7.4 Europe Management of Antithrombin Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Management of Antithrombin Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Management of Antithrombin Market Size by Type (2020-2031)
8.4 Asia-Pacific Management of Antithrombin Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Management of Antithrombin Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Management of Antithrombin Market Size by Type (2020-2031)
9.4 Central and South America Management of Antithrombin Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Management of Antithrombin Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Management of Antithrombin Market Size by Type (2020-2031)
10.4 Middle East and Africa Management of Antithrombin Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Management of Antithrombin Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Business Overview
11.1.3 Grifols Management of Antithrombin Product Features and Attributes
11.1.4 Grifols Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.1.5 Grifols Management of Antithrombin Revenue by Product in 2024
11.1.6 Grifols Management of Antithrombin Revenue by Application in 2024
11.1.7 Grifols Management of Antithrombin Revenue by Geographic Area in 2024
11.1.8 Grifols Management of Antithrombin SWOT Analysis
11.1.9 Grifols Recent Developments
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Corporation Information
11.2.2 rEVO Biologics Inc. Business Overview
11.2.3 rEVO Biologics Inc. Management of Antithrombin Product Features and Attributes
11.2.4 rEVO Biologics Inc. Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.2.5 rEVO Biologics Inc. Management of Antithrombin Revenue by Product in 2024
11.2.6 rEVO Biologics Inc. Management of Antithrombin Revenue by Application in 2024
11.2.7 rEVO Biologics Inc. Management of Antithrombin Revenue by Geographic Area in 2024
11.2.8 rEVO Biologics Inc. Management of Antithrombin SWOT Analysis
11.2.9 rEVO Biologics Inc. Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Business Overview
11.3.3 Takeda Management of Antithrombin Product Features and Attributes
11.3.4 Takeda Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.3.5 Takeda Management of Antithrombin Revenue by Product in 2024
11.3.6 Takeda Management of Antithrombin Revenue by Application in 2024
11.3.7 Takeda Management of Antithrombin Revenue by Geographic Area in 2024
11.3.8 Takeda Management of Antithrombin SWOT Analysis
11.3.9 Takeda Recent Developments
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Corporation Information
11.4.2 Kedrion S.p.A. Business Overview
11.4.3 Kedrion S.p.A. Management of Antithrombin Product Features and Attributes
11.4.4 Kedrion S.p.A. Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.4.5 Kedrion S.p.A. Management of Antithrombin Revenue by Product in 2024
11.4.6 Kedrion S.p.A. Management of Antithrombin Revenue by Application in 2024
11.4.7 Kedrion S.p.A. Management of Antithrombin Revenue by Geographic Area in 2024
11.4.8 Kedrion S.p.A. Management of Antithrombin SWOT Analysis
11.4.9 Kedrion S.p.A. Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Business Overview
11.5.3 CSL Limited Management of Antithrombin Product Features and Attributes
11.5.4 CSL Limited Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.5.5 CSL Limited Management of Antithrombin Revenue by Product in 2024
11.5.6 CSL Limited Management of Antithrombin Revenue by Application in 2024
11.5.7 CSL Limited Management of Antithrombin Revenue by Geographic Area in 2024
11.5.8 CSL Limited Management of Antithrombin SWOT Analysis
11.5.9 CSL Limited Recent Developments
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Corporation Information
11.6.2 Scripps Laboratories Inc. Business Overview
11.6.3 Scripps Laboratories Inc. Management of Antithrombin Product Features and Attributes
11.6.4 Scripps Laboratories Inc. Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.6.5 Scripps Laboratories Inc. Recent Developments
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Corporation Information
11.7.2 Lee Biosolutions Business Overview
11.7.3 Lee Biosolutions Management of Antithrombin Product Features and Attributes
11.7.4 Lee Biosolutions Management of Antithrombin Revenue and Gross Margin (2020-2025)
11.7.5 Lee Biosolutions Recent Developments
12 Management of AntithrombinIndustry Chain Analysis
12.1 Management of Antithrombin Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Management of Antithrombin Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Management of Antithrombin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Grifols S A
REVO Biologics Inc
Takeda
Kedrion S p A
CSL Limited
Scripps Laboratories Inc
Lee Biosolutions
List of Tables
 Table 1. Global Management of Antithrombin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Management of Antithrombin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Management of Antithrombin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Management of Antithrombin Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Management of Antithrombin Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Management of Antithrombin Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Management of Antithrombin Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Management of Antithrombin by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Management of Antithrombin as of 2024)
 Table 11. Global Management of Antithrombin Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Management of Antithrombin Companies Headquarters
 Table 13. Global Management of Antithrombin Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Management of Antithrombin Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Management of Antithrombin Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Management of Antithrombin Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Management of Antithrombin Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Management of Antithrombin High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Management of Antithrombin Growth Accelerators and Market Barriers
 Table 25. North America Management of Antithrombin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Management of Antithrombin Growth Accelerators and Market Barriers
 Table 27. Europe Management of Antithrombin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Management of Antithrombin Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Management of Antithrombin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Management of Antithrombin Investment Opportunities and Key Challenges
 Table 31. Central and South America Management of Antithrombin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Management of Antithrombin Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Management of Antithrombin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Grifols Corporation Information
 Table 35. Grifols Description and Major Businesses
 Table 36. Grifols Product Features and Attributes
 Table 37. Grifols Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Grifols Revenue Proportion by Product in 2024
 Table 39. Grifols Revenue Proportion by Application in 2024
 Table 40. Grifols Revenue Proportion by Geographic Area in 2024
 Table 41. Grifols Management of Antithrombin SWOT Analysis
 Table 42. Grifols Recent Developments
 Table 43. rEVO Biologics Inc. Corporation Information
 Table 44. rEVO Biologics Inc. Description and Major Businesses
 Table 45. rEVO Biologics Inc. Product Features and Attributes
 Table 46. rEVO Biologics Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. rEVO Biologics Inc. Revenue Proportion by Product in 2024
 Table 48. rEVO Biologics Inc. Revenue Proportion by Application in 2024
 Table 49. rEVO Biologics Inc. Revenue Proportion by Geographic Area in 2024
 Table 50. rEVO Biologics Inc. Management of Antithrombin SWOT Analysis
 Table 51. rEVO Biologics Inc. Recent Developments
 Table 52. Takeda Corporation Information
 Table 53. Takeda Description and Major Businesses
 Table 54. Takeda Product Features and Attributes
 Table 55. Takeda Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Takeda Revenue Proportion by Product in 2024
 Table 57. Takeda Revenue Proportion by Application in 2024
 Table 58. Takeda Revenue Proportion by Geographic Area in 2024
 Table 59. Takeda Management of Antithrombin SWOT Analysis
 Table 60. Takeda Recent Developments
 Table 61. Kedrion S.p.A. Corporation Information
 Table 62. Kedrion S.p.A. Description and Major Businesses
 Table 63. Kedrion S.p.A. Product Features and Attributes
 Table 64. Kedrion S.p.A. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Kedrion S.p.A. Revenue Proportion by Product in 2024
 Table 66. Kedrion S.p.A. Revenue Proportion by Application in 2024
 Table 67. Kedrion S.p.A. Revenue Proportion by Geographic Area in 2024
 Table 68. Kedrion S.p.A. Management of Antithrombin SWOT Analysis
 Table 69. Kedrion S.p.A. Recent Developments
 Table 70. CSL Limited Corporation Information
 Table 71. CSL Limited Description and Major Businesses
 Table 72. CSL Limited Product Features and Attributes
 Table 73. CSL Limited Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. CSL Limited Revenue Proportion by Product in 2024
 Table 75. CSL Limited Revenue Proportion by Application in 2024
 Table 76. CSL Limited Revenue Proportion by Geographic Area in 2024
 Table 77. CSL Limited Management of Antithrombin SWOT Analysis
 Table 78. CSL Limited Recent Developments
 Table 79. Scripps Laboratories Inc. Corporation Information
 Table 80. Scripps Laboratories Inc. Description and Major Businesses
 Table 81. Scripps Laboratories Inc. Product Features and Attributes
 Table 82. Scripps Laboratories Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Scripps Laboratories Inc. Recent Developments
 Table 84. Lee Biosolutions Corporation Information
 Table 85. Lee Biosolutions Description and Major Businesses
 Table 86. Lee Biosolutions Product Features and Attributes
 Table 87. Lee Biosolutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Lee Biosolutions Recent Developments
 Table 89. Raw Materials Key Suppliers
 Table 90. Distributors List
 Table 91. Market Trends and Market Evolution
 Table 92. Market Drivers and Opportunities
 Table 93. Market Challenges, Risks, and Restraints
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources


List of Figures
 Figure 1. Management of Antithrombin Product Picture
 Figure 2. Global Management of Antithrombin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Liquid Product Picture
 Figure 4. Lyophilized Product Picture
 Figure 5. Global Management of Antithrombin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Diagnostics
 Figure 7. Therapeutics
 Figure 8. Research
 Figure 9. Management of Antithrombin Report Years Considered
 Figure 10. Global Management of Antithrombin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Management of Antithrombin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Management of Antithrombin Revenue Market Share by Region (2020-2031)
 Figure 14. Global Management of Antithrombin Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Liquid Revenue Market Share by Player in 2024
 Figure 17. Lyophilized Revenue Market Share by Player in 2024
 Figure 18. Global Management of Antithrombin Revenue Market Share by Type (2020-2031)
 Figure 19. Global Management of Antithrombin Revenue Market Share by Application (2020-2031)
 Figure 20. North America Management of Antithrombin Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Management of Antithrombin Revenue (US$ Million) in 2024
 Figure 22. North America Management of Antithrombin Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Management of Antithrombin Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Management of Antithrombin Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Management of Antithrombin Revenue (US$ Million) in 2024
 Figure 29. Europe Management of Antithrombin Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Management of Antithrombin Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 32. France Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Management of Antithrombin Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Management of Antithrombin Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Management of Antithrombin Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Management of Antithrombin Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 44. India Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Management of Antithrombin Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Management of Antithrombin Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Management of Antithrombin Revenue (US$ Million) in 2024
 Figure 52. Central and South America Management of Antithrombin Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Management of Antithrombin Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Management of Antithrombin Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Management of Antithrombin Revenue (US$ Million) in 2024
 Figure 58. South America Management of Antithrombin Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Management of Antithrombin Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Management of Antithrombin Revenue (2020-2025) & (US$ Million)
 Figure 64. Management of Antithrombin Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombin Inhibitor Market Research Report 2024
Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti thrombin III Testing Market Insights Forecast to 2030
Global Factor Xa Inhibitors Market Research Report 2024
Global Human Thrombin Market Research Report 2024
Global Recombinant Human Thrombin Protein Market Research Report 2024
Global Anticoagulant Medicines Market Research Report 2025
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Antithrombotic Treatment Market Insights Forecast to 2030
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticoagulant Treatment Market Insights Forecast to 2030
Global Heparin Market Insights Forecast to 2030
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Global Human Antithrombin III Market Research Report 2024
Global Intravenous Anticoagulants Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Thrombosis Drug Market Research Report 2025
Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions